A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
Completed · Phase 1
Conditions studied: Healthy Adults
In brief
The purpose of the study is to see and learn the effect of multiple doses of a strong CYP3A4 inhibitor and a potent UGT2B7 inhibitor on the PK of PF-07220060.
Key facts
- Study ID
- NCT07160738
- Run by
- Pfizer
- People needed
- 25
- Starts
- 2025-09-22
- Expected to finish
- 2025-12-22
- Last updated by the study team
- 2026-04-03
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Pfizer Clinical Research Unit - New Haven — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.